Encrantz Staffan bought SGHT
June 6, 2024 · Form 4 insider transaction
Encrantz Staffan bought 17,366 shares of Sight Sciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $120,000 divided by the closing price of the Common Stock on the grant date, June 6, 2024. The RSUs vest on the earlier of June 6, 2025 and the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.; Includes (i) 1,012,150 shares of Common Stock and (ii) 17,366 RSUs, which are subject to vesting as reported herein.